title: A Cysteine Substitution Probes β3H267 Interactions with Propofol and Other Potent Anesthetics in α1β3γ2L γ-Aminobutyric Acid Type A Receptors.
abstract: BACKGROUND
  Anesthetic contact residues in γ-aminobutyric acid type A (GABAA) receptors have been identified using photolabels, including two propofol derivatives. O-propofol diazirine labels H267 in β3 and α1β3 receptors, whereas m-azi-propofol labels other residues in intersubunit clefts of α1β3. Neither label has been studied in αβγ receptors, the most common isoform in mammalian brain. In αβγ receptors, other anesthetic derivatives photolabel m-azi-propofol-labeled residues, but not βH267. The authors' structural homology model of α1β3γ2L receptors suggests that β3H267 may abut some of these sites.
  
  
  METHODS
  Substituted cysteine modification-protection was used to test β3H267C interactions with four potent anesthetics: propofol, etomidate, alphaxalone, and R-5-allyl-1-methyl-5-(m-trifluoromethyl-diazirinylphenyl) barbituric acid (mTFD-MPAB). The authors expressed α1β3γ2L or α1β3H267Cγ2L GABAA receptors in Xenopus oocytes. The authors used voltage clamp electrophysiology to assess receptor sensitivity to γ-aminobutyric acid (GABA) and anesthetics and to compare p-chloromercuribenzenesulfonate modification rates with GABA versus GABA plus anesthetics.
  
  
  RESULTS
  Enhancement of low GABA (eliciting 5% of maximum) responses by equihypnotic concentrations of all four anesthetics was similar in α1β3γ2L and α1β3H267Cγ2L receptors (n > 3). Direct activation of α1β3H267Cγ2L receptors, but not α1β3γ2L, by mTFD-MPAB and propofol was significantly greater than the other anesthetics. Modification of β3H267C by p-chloromercuribenzenesulfonate (n > 4) was rapid and accelerated by GABA. Only mTFD-MPAB slowed β3H267C modification (approximately twofold; P = 0.011).
  
  
  CONCLUSIONS
  β3H267 in α1β3γ2L GABAA receptors contacts mTFD-MPAB, but not propofol. The study results suggest that β3H267 is near the periphery of one or both transmembrane intersubunit (α+/β- and γ+/β-) pockets where both mTFD-MPAB and propofol bind.
authors.affiliation: From the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.
authors.forename: Alex T
authors.initials: AT
authors.lastname: Stern
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Forman
mesh_terms: D019943:Amino Acid Substitution; D000777:Anesthetics / Q000494:pharmacology; D018686:Anesthetics, Intravenous / Q000494:pharmacology*; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D003545:Cysteine; D055724:Electrophysiological Phenomena / Q000187:drug effects; D005045:Etomidate / Q000494:pharmacology; D005260:Female; D011277:Pregnanediones / Q000494:pharmacology; D015742:Propofol / Q000494:pharmacology*; D018079:Receptors, GABA / Q000187:drug effects*; D014982:Xenopus laevis
chemical_list: D000777:Anesthetics; D018686:Anesthetics, Intravenous; D001463:Barbiturates; D011277:Pregnanediones; D018079:Receptors, GABA; C006477:alphaxalone; D003545:Cysteine; C032232:barbituric acid; D015742:Propofol; D005045:Etomidate